
Naresh Kumar Peddi
About Naresh Kumar Peddi
Data last updated:
Naresh Kumar Peddi is a Director at Sri Anantha Padmanabha Swamy Pharma Private Limited (since 2013) and Director at Brighid Biologicals Private Limited (since 2019). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹9.30 Cr; the largest is Sri Anantha Padmanabha Swamy Pharma Private Limited at ₹8.58 Cr (FY 2024). Earlier, Naresh Kumar Peddi was an Additional Director at Elixir Therapeutics Private Limited (from 2012).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Apr 2013 | 2013 | ₹8.58 Cr (FY 2024) | Active | |
| Director | 18 Nov 2019 | 2019 | ₹72 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 04 Apr 2012 | 2006 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Naresh Kumar Peddi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Alok Agarwal | 00820427 | Sri Anantha Padmanabha Swamy Pharma Private Limited | Director |
| Bhaskar Karshikallam | 06542029 | Sri Anantha Padmanabha Swamy Pharma Private Limited | Director |
| Peddi Jagadishwar | 00071114 | Sri Anantha Padmanabha Swamy Pharma Private Limited | Director |
| Renu Goyal | 06542030 | Sri Anantha Padmanabha Swamy Pharma Private Limited | Director |
| Vallabadas Satyanarayana Goud | 00228790 | Sri Anantha Padmanabha Swamy Pharma Private Limited | Director |
| Sribhavya Gupta Kanduri | 08614736 | Brighid Biologicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naresh Kumar Peddi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naresh Kumar Peddi
Naresh Kumar Peddi currently holds 2 directorships: Sri Anantha Padmanabha Swamy Pharma Private Limited (Director, since 07 Apr 2013, revenue ₹8.58 Cr (FY 2024)); Brighid Biologicals Private Limited (Director, since 18 Nov 2019, revenue ₹72 Lakh (FY 2024)).
Naresh Kumar Peddi was first appointed on 04 Apr 2012 as Additional Director at Elixir Therapeutics Private Limited. The most recent appointment on record is 18 Nov 2019 at Brighid Biologicals Private Limited.
The 2 current companies of Naresh Kumar Peddi that report revenue have a combined latest revenue of ₹9.30 Cr: Sri Anantha Padmanabha Swamy Pharma Private Limited ₹8.58 Cr (FY 2024); Brighid Biologicals Private Limited ₹72 Lakh (FY 2024).
Naresh Kumar Peddi held 1 earlier board appointment: Elixir Therapeutics Private Limited (Additional Director, from 04 Apr 2012).
The current boards of Naresh Kumar Peddi's companies include Alok Agarwal (Sri Anantha Padmanabha Swamy Pharma Private Limited), Bhaskar Karshikallam (Sri Anantha Padmanabha Swamy Pharma Private Limited), Peddi Jagadishwar (Sri Anantha Padmanabha Swamy Pharma Private Limited), Renu Goyal (Sri Anantha Padmanabha Swamy Pharma Private Limited), Vallabadas Satyanarayana Goud (Sri Anantha Padmanabha Swamy Pharma Private Limited), Sribhavya Gupta Kanduri (Brighid Biologicals Private Limited).